Why IXC is a Strong BUY awaiting Phase 2 results in March 2020, page-29

Some interesting and well thought out opinions here. I hate the threads that are all "this is going to the moon" or "this is going to crash to zero" without any basis.

i was having a coffee with one of the top 20 holders a couple of weeks ago and discussed the price/market cap potential. I got in on the float at 40c and mentioned that if some good news flowed it wouldn't take much to hit $2 given how tight the register is. He agreed and stated given the orphan drug status the risk was far lower than a genuine start up biotech and what got him invested was not the IIH disease treatment but rather the treatment of head injury potential which is far more common.
We both agreed this still remains a very speculative investment but his view was success would see $5 quite easily. Failure could see it worth next to nothing obviously.
I'm in for the story to play out.
cheers